Literature DB >> 23526140

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Don Husereau1, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H Briggs, Josephine Mauskopf, Elizabeth Loder.   

Abstract

Economic evaluations of health interventions pose a particular challenge for reporting. There is also a need to consolidate and update existing guidelines and promote their use in a user friendly manner. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement is an attempt to consolidate and update previous health economic evaluation guidelines efforts into one current, useful reporting guidance. The primary audiences for the CHEERS statement are researchers reporting economic evaluations and the editors and peer reviewers assessing them for publication. The need for new reporting guidance was identified by a survey of medical editors. A list of possible items based on a systematic review was created. A two round, modified Delphi panel consisting of representatives from academia, clinical practice, industry, government, and the editorial community was conducted. Out of 44 candidate items, 24 items and accompanying recommendations were developed. The recommendations are contained in a user friendly, 24 item checklist. A copy of the statement, accompanying checklist, and this report can be found on the ISPOR Health Economic Evaluations Publication Guidelines Task Force website ( www.ispor.org/TaskForces/EconomicPubGuidelines.asp). We hope CHEERS will lead to better reporting, and ultimately, better health decisions. To facilitate dissemination and uptake, the CHEERS statement is being co-published across 10 health economics and medical journals. We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years.

Mesh:

Year:  2013        PMID: 23526140     DOI: 10.1007/s10198-013-0471-6

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  22 in total

1.  The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial.

Authors:  S M Campbell; M Hann; M O Roland; J A Quayle; P G Shekelle
Journal:  Med Care       Date:  1999-09       Impact factor: 2.983

2.  The quality of reporting in published cost-utility analyses, 1976-1997.

Authors:  P J Neumann; P W Stone; R H Chapman; E A Sandberg; C M Bell
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

3.  Reporting format for economic evaluation. Part II: Focus on modelling studies.

Authors:  M J Nuijten; M H Pronk; M J Brorens; Y A Hekster; J H Lockefeer; P A de Smet; G Bonsel; A van der Kuy
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 4.  Describing reporting guidelines for health research: a systematic review.

Authors:  David Moher; Laura Weeks; Mary Ocampo; Dugald Seely; Margaret Sampson; Douglas G Altman; Kenneth F Schulz; Donald Miller; Iveta Simera; Jeremy Grimshaw; John Hoey
Journal:  J Clin Epidemiol       Date:  2011-01-08       Impact factor: 6.437

Review 5.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Authors:  Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed
Journal:  Value Health       Date:  2005 Sep-Oct       Impact factor: 5.725

6.  Quality of abstracts of papers reporting original cost-effectiveness analyses.

Authors:  Allison B Rosen; Dan Greenberg; Patricia W Stone; Natalia V Olchanski; Peter J Neumann
Journal:  Med Decis Making       Date:  2005 Jul-Aug       Impact factor: 2.583

7.  The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

Authors:  William F McGhan; Maiwenn Al; Jalpa A Doshi; Isao Kamae; Steven E Marx; Donna Rindress
Journal:  Value Health       Date:  2009-09-10       Impact factor: 5.725

8.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Value Health       Date:  2013 Mar-Apr       Impact factor: 5.725

9.  Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.

Authors: 
Journal:  Ann Intern Med       Date:  1995-07-01       Impact factor: 25.391

10.  Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting.

Authors:  Stavros Petrou; Alastair Gray
Journal:  BMJ       Date:  2011-04-11
View more
  69 in total

1.  Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review.

Authors:  Alfredo Palacios; Carlos Rojas-Roque; Lucas González; Ariel Bardach; Agustín Ciapponi; Claudia Peckaitis; Andres Pichon-Riviere; Federico Augustovski
Journal:  Pharmacoeconomics       Date:  2021-03-30       Impact factor: 4.981

2.  Key considerations for advancing the development and testing of mHealth interventions in adolescent and young adult oncology.

Authors:  Casey A Walsh; Abby R Rosenberg; Nancy Lau; Karen L Syrjala
Journal:  Psychooncology       Date:  2019-10-09       Impact factor: 3.894

3.  Disability-adjusted life years due to chronic and hidden hunger under food system evolution with climate change and adaptation to 2050.

Authors:  Timothy B Sulser; Robert H Beach; Keith D Wiebe; Shahnila Dunston; Naomi K Fukagawa
Journal:  Am J Clin Nutr       Date:  2021-08-02       Impact factor: 7.045

4.  Robotic versus laparoscopic surgery for rectal cancer: a comparative cost-effectiveness study.

Authors:  Y Quijano; J Nuñez-Alfonsel; B Ielpo; V Ferri; R Caruso; H Durán; E Díaz; L Malavé; I Fabra; E Pinna; R Isernia; Á Hidalgo; E Vicente
Journal:  Tech Coloproctol       Date:  2020-02-04       Impact factor: 3.781

Review 5.  A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures.

Authors:  L Si; T M Winzenberg; A J Palmer
Journal:  Osteoporos Int       Date:  2013-10-24       Impact factor: 4.507

6.  Economic Evaluation of a Reablement Training Program for Homecare Staff Targeting Sedentary Behavior in Community-Dwelling Older Adults Compared to Usual Care: A Cluster Randomized Controlled Trial.

Authors:  Teuni H Rooijackers; Silke F Metzelthin; Erik van Rossum; Gertrudis I J M Kempen; Silvia M A A Evers; Andrea Gabrio; G A Rixt Zijlstra
Journal:  Clin Interv Aging       Date:  2021-12-22       Impact factor: 4.458

7.  Cost-effectiveness of Interventions to Increase HPV Vaccine Uptake.

Authors:  Jennifer C Spencer; Noel T Brewer; Justin G Trogdon; Morris Weinberger; Tamera Coyne-Beasley; Stephanie B Wheeler
Journal:  Pediatrics       Date:  2020-11-16       Impact factor: 7.124

8.  Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.

Authors:  Chris Stinton; Mary Jordan; Hannah Fraser; Peter Auguste; Rachel Court; Lena Al-Khudairy; Jason Madan; Dimitris Grammatopoulos; Sian Taylor-Phillips
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

9.  A general framework for classifying costing methods for economic evaluation of health care.

Authors:  Zuzana Špacírová; David Epstein; Leticia García-Mochón; Joan Rovira; Antonio Olry de Labry Lima; Jaime Espín
Journal:  Eur J Health Econ       Date:  2020-01-20

10.  Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective.

Authors:  Jeremy Sharib; Laura Esserman; Eugene J Koay; Anirban Maitra; Yu Shen; Kimberly S Kirkwood; Elissa M Ozanne
Journal:  Surgery       Date:  2020-07-29       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.